{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04958109",
            "orgStudyIdInfo": {
                "id": "267339"
            },
            "organization": {
                "fullName": "Massachusetts General Hospital",
                "class": "OTHER"
            },
            "briefTitle": "Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test",
            "officialTitle": "Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "evaluation-of-kisspeptin-glucose-stimulated-insulin-secretion-with-oral-glucose-tolerance-test"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-10-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-07-01",
            "studyFirstSubmitQcDate": "2021-07-09",
            "studyFirstPostDateStruct": {
                "date": "2021-07-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-07-17",
            "lastUpdatePostDateStruct": {
                "date": "2023-07-19",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Stephanie B. Seminara, MD",
                "investigatorTitle": "Chief, Reproductive Endocrine Unit; Professor of Medicine, Harvard Medical School; Director, Harvard Reproductive Endocrine Sciences Center",
                "investigatorAffiliation": "Massachusetts General Hospital"
            },
            "leadSponsor": {
                "name": "Massachusetts General Hospital",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this study is to understand how exogenous kisspeptin affects metabolism by evaluating responses to an oral glucose tolerance test",
            "detailedDescription": "Assignment: Each study subject will serve as their own control. The order of the visits will be randomized.\n\nDelivery of Interventions:\n\n* Prior to the study visit, subjects will undergo a review of their medical history and screening laboratories.\n* During the inpatient study, the subjects will\n\n  * Undergo a 16-hour kisspeptin infusion\n  * Undergo an oral glucose tolerance test"
        },
        "conditionsModule": {
            "conditions": [
                "Metabolic Diseases"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 16,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Kisspeptin",
                    "type": "EXPERIMENTAL",
                    "description": "\u2022 Intravenous administration of kisspeptin 112-121 x 16 hours",
                    "interventionNames": [
                        "Diagnostic Test: Oral Glucose Tolerance Test",
                        "Drug: Kisspeptin"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "\u2022 Intravenous administration of placebo x 16 hours",
                    "interventionNames": [
                        "Diagnostic Test: Oral Glucose Tolerance Test",
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Oral Glucose Tolerance Test",
                    "description": "Administration of a 75 gm oral glucose tolerance test",
                    "armGroupLabels": [
                        "Kisspeptin",
                        "Placebo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Kisspeptin",
                    "description": "Intravenous administration of kisspeptin 112-121 x 16 hours",
                    "armGroupLabels": [
                        "Kisspeptin"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Intravenous administration of Placebo 16 hours",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Average Difference in Oral glucose Sensitivity Index (Kisspeptin-Placebo)",
                    "description": "Change in Oral glucose Sensitivity Index between kisspeptin and placebo arms in OGTT",
                    "timeFrame": "2 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nHistory:\n\n* over the age of 18,\n* normal pubertal development\n* stable weight for previous three months,\n* normal body mass index (BMI between 18.5-25)\n* regular menstrual cycles\n\nPhysical examination:\n\n\u2022 systolic BP \\< 140 mm Hg, diastolic \\< 90 mm Hg\n\nLaboratory studies: (per MGH reference ranges)\n\n* normal hemoglobin\n* hemoglobin A1C \\< 6.5%\n* BUN, creatinine not elevated\n* AST, ALT \\< 3x upper limit of normal\n\nExclusion Criteria:\n\n* active illicit drug use,\n* history of a medication reaction requiring emergency medical care,\n* difficulty with blood draws.\n* history of chronic disease, except well controlled thyroid disease,\n* recent use of prescription medications which interfere with metabolism or reproduction (recent = within 5 half-lives of the drug). Use of levothyroxine or seasonal allergy medications is acceptable,\n* history of diabetes in a first degree relative,\n* use of contraceptive pills, patches or vaginal rings within last 4 weeks.\n* hyperlipidemia by fasting lipid panel\n* positive serum pregnancy test (for all women)",
            "healthyVolunteers": true,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "maximumAge": "40 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Margaret Lippincott, MD",
                    "role": "CONTACT",
                    "phone": "617-726-8434",
                    "email": "MGHKisspeptinResearch@partners.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Margaret Lippincott, MD",
                    "affiliation": "Massachusetts General Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Margaret Lippincott, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "asFound": "Metabolic Diseases",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M10365",
                    "name": "Insulin",
                    "relevance": "LOW"
                },
                {
                    "id": "M173166",
                    "name": "Insulin, Globin Zinc",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}